Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

HWEL

Healthwell Acquisition C... (HWEL)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:HWEL
DataOraFonteTitoloSimboloCompagnia
18/11/202303:29Business WireHealthwell Acquisition Corp. I Announces Cancellation of Special Stockholder Meeting and its Intention to LiquidateNASDAQ:HWELHealthwell Acquisition Corporation I
04/11/202300:00Business WireHealthwell Acquisition Corp. I Announces Termination of Business Combination with Starton Therapeutics, Inc.NASDAQ:HWELHealthwell Acquisition Corporation I
24/10/202305:55Business WireHealthwell Acquisition Corp. I Announces Postponement of the Special Meeting of Stockholders to Approve the Proposed Business Combination with Starton Therapeutics, Inc. and Related TransactionsNASDAQ:HWELHealthwell Acquisition Corporation I
17/10/202312:00Business WireHealthwell Acquisition Corp. I Announces New Meeting Date for the Special Meeting of Stockholders to Approve Proposed Business Combination With Starton Therapeutics, Inc. and Related TransactionsNASDAQ:HWELHealthwell Acquisition Corporation I
04/10/202314:00Business WireStarton Therapeutics Doses First Patient in Landmark STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple MyelomaNASDAQ:HWELHealthwell Acquisition Corporation I
13/09/202322:05Business WireStarton Therapeutics Announces the Opening of the First Clinical Site for STAR-LLD Lenalidomide Phase 1b Trial in Multiple MyelomaNASDAQ:HWELHealthwell Acquisition Corporation I
10/07/202313:00Business WireStarton Therapeutics Contracts Global Clinical Research Organization to Conduct STAR-LLD Phase 1b Clinical Trial in Multiple MyelomaNASDAQ:HWELHealthwell Acquisition Corporation I
23/06/202323:20Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:HWELHealthwell Acquisition Corporation I
13/06/202316:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HWELHealthwell Acquisition Corporation I
13/06/202316:28Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:HWELHealthwell Acquisition Corporation I
12/06/202322:30Business WireStarton Therapeutics Receives Authorization from the FDA to Proceed with STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple MyelomaNASDAQ:HWELHealthwell Acquisition Corporation I
07/06/202316:52Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:HWELHealthwell Acquisition Corporation I
06/06/202314:00Business WireStarton Therapeutics, Inc. and Healthwell Acquisition Corp. I to Present at the Jefferies Healthcare ConferenceNASDAQ:HWELHealthwell Acquisition Corporation I
18/05/202323:10Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:HWELHealthwell Acquisition Corporation I
15/05/202322:21Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:HWELHealthwell Acquisition Corporation I
27/04/202313:00Business WireStarton Therapeutics Inc. and Healthwell Acquisition Corp. I to Combine and Create Publicly Traded Leader in Proprietary Continuous Delivery Technology for Cancer TreatmentsNASDAQ:HWELHealthwell Acquisition Corporation I
14/02/202323:42Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:HWELHealthwell Acquisition Corporation I
10/02/202323:02Edgar (US Regulatory)

NASDAQ:HWELHealthwell Acquisition Corporation I
28/03/202223:23Edgar (US Regulatory)Annual Report (10-k)NASDAQ:HWELHealthwell Acquisition Corporation I
22/11/202112:02Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:HWELHealthwell Acquisition Corporation I
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:HWEL
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network